1YBottom 25% of the group
Rank 52 of 63 funds
Return +15.44%
1Y returns of 63 funds in the Health Care group, sorted from highest to lowest. This fund ranks 52No. 1 is SCBGENOME(E) +62.13%
TISCO Global Healthcare Stars Plus Fund
Shows where this fund stands in its group. Not investment advice · Data as of 3 Nov 2026
TGHSTARP is a fund of funds that puts 98.30% into units of other funds, spread across several funds
This fundTGHSTARPThis fund's manager selects the funds and adjusts their weights. The funds it holds also charge their own fees
All funds, as disclosed in the AMC fact sheet · The stocks these funds hold are shown below · This fund's performance therefore depends on the funds it holds
Eli Lilly and Co LLY5.91%
Johnson & Johnson JNJ5.32%Over the past year it was in the bottom 25% of its group; over 5 years it returned −0.37% per year (Below half the group)
No. 1 is SCBGENOME(E) +62.13%
Each bar is one fund in the AIMC Health Care group, sorted from highest to lowest return · Every share class is counted, and only funds with a full track record for the period are included · Calculated from NAV as of 3 Nov 2026
Past performance is not a guarantee of future results
| YTD | 1W | 2W | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y | MAX |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +8.02% | +2.58% | +4.74% | +8.05% | +7.59% | +15.80% | +15.53% | +21.24% | −1.82% | +34.66% | +73.10% |
Largest drawdown in the selected period −28.75% Previous peak 20 Jul 2015 (NAV 10.5835) → Trough 8 Feb 2016 (NAV 7.5404) · Back to the previous peak on 13 Dec 2019, after 3 years 10 months
Currently −3.49% from the peak NAV of 13.7905 (2 Sep 2021)
Over 5 years, TGHSTARP returned -0.03 per unit of volatility, ranking 19 of 33 funds · The highest is FP HCARE-A (0.43)
กองทุนจะลงทุนในหรือมีไว้ซึ่งหน่วยลงทุนของกองทุนรวมตราสารทุนต่างประเทศ และ/หรือกองทุนรวมอีทีเอฟตราสารทุนต่างประเทศ ที่มีนโยบายการลงทุนในตราสารทุนของบริษัทที่ดำเนินธุรกิจที่เกี่ยวข้องกับอุตสาหกรรม Healthcare หรือบริษัทที่มีรายได้หลักจากการประกอบกิจการที่เกี่ยวข้องกับอุตสาหกรรม Healthcare… Its largest holdings are BLACKROCK GLOBAL FUNDS- WORLD HEALTHSCIENCE FUND A2 61.64% · JANUS GLOBAL LIFE SCIENCES FUND A USD 36.66% (fact sheet 30 Sep 2026)
Risk level 7 of 8 (High risk). Since 20 May 2015, its NAV has fallen as much as −28.75% from its peak.
Actual total expense ratio (TER) 1.90% a year, against a ceiling of 4.82%. Management fee 1.61%. Front-end fee 1.25%. Back-end fee 0.00%. (Fact sheet 30 Sep 2026)
No. Gains or losses accumulate in the NAV, and investors receive their return when they redeem units
Past performance is not a guarantee of future results · Investing involves risk. Investors should understand the product's features, return conditions and risks before making an investment decision · This fund invests abroad, so investors may lose or gain from exchange rate movements
ABBVIE ABBV
Merck & MRK3.65%
Roche ROG3.00%
Thermo Fisher TMO2.55%
Novartis NOVN2.52%
Gilead Sciences GILD2.31%
Amgen AMGN2.03%
Unitedhealth Group UNH1.95%Eli Lilly and Co LLYDiabetes and weight-loss drugs
An American medicines and medical devices company, with products such as cancer drugs and surgical instruments
ABBVIE ABBVHospitals, medicines and medical equipment
Merck & MRKHospitals, medicines and medical equipment
Roche ROGHospitals, medicines and medical equipment
Thermo Fisher TMOAn American company selling scientific instruments, reagents and services for laboratories
Novartis NOVNHospitals, medicines and medical equipment
Gilead Sciences GILDA US drug company making HIV treatment and prevention drugs, hepatitis drugs and cancer drugs
Amgen AMGNHospitals, medicines and medical equipment
Hospitals, medicines and medical equipment
Based on each ETF's actual share of the fund's value · Weighted by each fund held × the stocks that fund holds, covering 63% of the money invested in other funds. Uses each fund's top 10, so figures are a minimum · BlackRock Global Funds - World Healthscience as of 9 Oct 2026 · Illustrations are for explanation only, not individual stock recommendations
No. 1 is SCBGENOME(E) +21.97% per year
No. 1 is FP HCARE-A +6.61% per year
| +33.10% |
Total return over each period, matching the NAV chart periods · Not annualised
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Full year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −0.6 | +1.9 | −7.1 | −0.8 | +2.1 | +6.1 | −0.7 | +3.3 | −1.7 | +6.8 | −0.8 | · | +8.0* |
| 2025 | +5.9 | −0.9 | −4.3 | −1.9 | −5.3 | +1.2 | −0.9 | +3.4 | +0.7 | +4.8 | +7.9 | −0.9 | +9.2 |
| 2024 | +2.8 | +2.5 | +1.7 | −3.8 | +1.9 | +2.5 | +1.2 | +3.3 | −4.2 | −3.7 | −1.1 | −7.4 | −5.0 |
| 2023 | −1.7 | −3.5 | +1.6 | +3.0 | −3.2 | +3.4 | −0.7 | −0.6 | −3.7 | −5.2 | +4.7 | +5.3 | −1.4 |
| 2022 | −9.7 | +0.1 | +4.2 | −5.2 | −1.4 | −1.3 | +3.6 | −4.9 | −3.5 | +6.8 | +2.9 | −1.2 | −10.3 |
Minimum first purchase 1,000 THB, subsequent purchases 1,000 THB. Buy orders accepted until 15:30, sell orders until 15:30, and redemption proceeds are paid T+5
Hedged at the manager's discretion. As of 30 Sep 2026, 91.65% of the value of its foreign investments was hedged